To check the effect of Menoveda Akira tablet in patients having menopause related mental health issues
- Conditions
- Health Condition 1: F068- Other specified mental disorders due to known physiological condition
- Registration Number
- CTRI/2023/01/049316
- Lead Sponsor
- Menoveda Lifesciences Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
1.Females from 45 to 70 years of age, post Menopause.
2.Females suffering from one or multiple mental health issues from- anxiety, insomnia, depression etc;
3.Females that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study.
4.Females willing to avoid participation in any other interventional clinical trial for the duration of the study.
1.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including oral or parenteral corticosteroids.
2.Females that have participated in any other interventional clinical trial in the previous 30 days.
3.Females with known sensitivity to any of the constituents of the investigational product.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method